Clinical trial / 2022
Intraduodenal quinine stimulated gut and pancreatic hormones and lowered glucose more than intragastric quinine in healthy men and women.
In a randomized, double-blind crossover study, 14 men and 14 women received 600 mg quinine hydrochloride (QHCl) via intragastric (IG) or intraduodenal (ID) administration on separate occasions. Suppression of ghrelin (P = 0.006), stimulation of cholecystokinin (P = 0.030), peptide YY (P = 0.017), GLP-1 (P = 0.034), insulin (P = 0.024), glucagon (P = 0.030), and pyloric pressures (P = 0.050), as well as glucose lowering (P = 0.001), were greater after ID-QHCl than IG-QHCl. In addition, insulin stimulation (P = 0.021) and glucose reduction (P = 0.001) were greater in females than males, while other measured hormones and pressures showed no sex differences.
- Study type
- Randomized, double-blind crossover trial
- Who was studied
- 14 healthy men and 14 healthy women
- What was measured
- Plasma gut/pancreatic hormones, glucose, and antropyloroduodenal pressures
THE PAPER
Quinine Effects on Gut and Pancreatic Hormones and Antropyloroduodenal Pressures in Humans-Role of Delivery Site and Sex.
Rezaie P, Bitarafan V, Rose BD, Lange K, Rehfeld JF, Horowitz M, Feinle-Bisset C. J Clin Endocrinol Metab, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.